Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

Oct-3A Inhibitors

Oct-3A inhibitors are a class of chemical compounds that function by selectively binding to and inhibiting the activity of the Oct-3A transcription factor. Oct-3A, also known as Octamer-binding transcription factor 3A, is a member of the POU family of transcription factors. It plays a critical role in regulating the expression of genes involved in cell differentiation, pluripotency, and self-renewal processes. The structural features of these inhibitors often consist of molecular scaffolds designed to interact with the DNA-binding domain of Oct-3A, preventing it from recognizing and binding to its specific DNA sequences. This binding disruption modulates the downstream expression of target genes that are otherwise regulated by Oct-3A. Due to the high specificity required to target transcription factors like Oct-3A, inhibitors in this class are generally designed to exhibit a high degree of affinity for the transcription factor's binding motifs and key protein regions involved in DNA interaction.

Chemically, Oct-3A inhibitors may encompass a variety of organic molecules, including small-molecule inhibitors, peptides, and even RNA-based compounds, depending on the strategy employed to disrupt Oct-3A activity. Small-molecule inhibitors, for example, are typically designed through structure-activity relationship (SAR) studies, which involve the iterative modification of a core molecular structure to improve binding affinity and specificity. Some inhibitors also function by inducing conformational changes in Oct-3A that destabilize its interactions with other transcriptional machinery. By inhibiting Oct-3A, researchers can explore the broader implications of transcriptional regulation in cellular pathways, as well as gain insight into the mechanisms governing cell fate determination, stem cell maintenance, and epigenetic modifications.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Alantolactone

546-43-0sc-480981
5 mg
$380.00
(0)

Induces degradation of Oct-3/4 by activating the ubiquitin-proteasome pathway.

Concanavalin A

11028-71-0sc-203007
sc-203007A
sc-203007B
50 mg
250 mg
1 g
$119.00
$364.00
$947.00
17
(2)

Lectin that can alter cell signaling and affect gene expression, potentially influencing Oct-3/4 expression indirectly.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylate cyclase, raising cAMP levels, which can lead to changes in cellular differentiation states affecting Oct-3/4.

Thiazovivin

1226056-71-8sc-361380
sc-361380A
10 mg
25 mg
$284.00
$634.00
15
(1)

ROCK inhibitor that can enhance cell survival and reprogramming, potentially modulating Oct-3/4 expression.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Inhibits TGF-β signaling, which can affect cell differentiation and Oct-3/4 expression.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$58.00
$188.00
$884.00
10
(1)

GSK-3 inhibitor that can stabilize β-catenin, influencing Wnt signaling and potentially affecting Oct-3/4 regulation.

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 (free base)sc-202651
5 mg
$151.00
4
(1)

Inhibits G9a histone methyltransferase, potentially affecting chromatin structure and gene expression, including Oct-3/4.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

DNA methyltransferase inhibitor that can lead to gene demethylation, possibly impacting Oct-3/4 expression.

SC1 (Pluripotin)

839707-37-8sc-255607
sc-255607A
sc-255607B
sc-255607C
1 mg
5 mg
10 mg
25 mg
$167.00
$199.00
$473.00
$779.00
(1)

Inhibits RasGAP and ERK1, which are involved in cell signaling and may affect Oct-3/4 regulation.

L-Ascorbic acid, free acid

50-81-7sc-202686
100 g
$46.00
5
(1)

Enhances the activity of histone demethylases, potentially influencing the epigenetic regulation of Oct-3/4.